Director Chambers Reveals a $4.9 Million SRPT Purchase

The most significant insider buy on today’s list comes via a Form 4 filing by Sarepta Therapeutics Inc $SRPT director Michael Andrew Chambers.

Chambers revealed a purchase of SRPT shares with a total value of $4.9 million.

Here’s The Hot Corner, with data from August 21, 2024:

In another Form 4, director Mark A. Alexander reported the acquisition of 2,000 shares of W. P. Carey Inc $WPC, equivalent to $114,059.

Last but not least, Rep. Kathy Manning of North Carolina filed a Periodic Transaction Report declaring purchases in Garmin Ltd $GRMN and Microsoft Corporation $MSFT.

GRMN has been carving out a base since 2021. Price is pressing against the range's upper bounds as buyers absorb all the overhead supply at this resistance zone:

The line in the sand lies at the 179 level. A breakout above that zone could push prices to a fresh leg to the upside.

Stay tuned. We'll be back on Thursday with more insider activity.

And please reach out with any questions. We love hearing from you!